How do I pitch C-Suite as a podcast guest?

C-Suite has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their business audience.

Who is the host of C-Suite?

C-Suite is hosted by Sanità33. The show is categorised under business (health) and has published 19 episodes.

How many episodes does C-Suite have?

C-Suite has published 19 episodes.

What topics does C-Suite cover?

C-Suite regularly covers business, health, fitness. It sits in the business category, with a health focus.

Is it hard to get booked on C-Suite?

C-Suite is accessible for guests with genuine business expertise. A personalised, episode-aware pitch will still outperform a generic one every time.

Is C-Suite currently accepting guest pitches?

C-Suite hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.

How long are C-Suite episodes?

Episodes of C-Suite average 14 minutes. a focused format where a clear narrative arc and tight preparation matter most.

What guest credentials does C-Suite typically look for?

Our data rates C-Suite's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.

business

C-Suite

Hosted by Sanità33 · business · IT · 19 episodes

Website

About this Podcast:

C-Suite racconta le storie dei C-Level che animano il settore Healthcare e Life Science e mostra come l’aspirazione a migliorare le cure passi anche dalle stesse persone che si sfidano ogni giorno in un settore sempre in evoluzione. Con questo podcast, vogliamo ispirarvi, motivarvi e farvi entrare nel mondo della Salute da un nuovo punto di vista: quello di chi ogni giorno si impegna per sollevare le vite dei cittadini. Preparatevi a viaggiare con noi attraverso le loro storie di successo. ___ C-Suite è un podcast di Sanità33 , il portale di informazione per la salute e le politiche sanitarie. Il podcast è condotto e realizzato da Ludovico Baldessin, CEO Edra SpA

Pitch Analysis

Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.

Contact path

Verified email

Booking probability

37%

Guest openness

Selective

Verified email on file

80/100

Required Score

Signup to Generate a Pitch

What is C-Suite?

C-Suite is a business podcast hosted by Sanità33, with 19 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

About the host

Sanità33 hosts C-Suite, a business show with 19 episodes published.

Verified host email: ████████@████.comSign in to unlock →

Recent episodes

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

C-Suite
Farmaco vegetale, Linari (Bionorica): "Mercato strategico per lo sviluppo del settore".
Jul 9, 20269 minS0
L'Italia rappresenta "un passaggio naturale nel percorso della nostra crescita" ed è "il secondo mercato più importante in Europa" per Bionorica. Lo afferma Marco Linari, Direttore commerciale e Vice CEO dell'azienda, intervistato da Sanità33 per la rubrica C-Suite, illustrando la strategia con cui il gruppo intende sviluppare il mercato italiano del farmaco vegetale. Ascolta ora l'episodio del podcast CSUITE - Riflessioni dei leader nel Life Science
Listen Show Notes
C-Suite
Malattie rare, Di Marco (Italfarmaco): “Givinostat ci ha portato in una nuova dimensione"
Jul 9, 20269 min
L'Italia rappresenta "un passaggio naturale nel percorso della nostra crescita" ed è "il secondo mercato più importante in Europa" per Bionorica. Lo afferma Marco Linari , Direttore commerciale e Vice CEO dell'azienda, intervistato da Sanità33 per la rubrica C-Suite, illustrando la strategia con cui il gruppo intende sviluppare il mercato italiano del farmaco vegetale. Ascolta ora l'episodio del podcast CSUITE - Riflessioni dei leader nel Life Science
Listen Show Notes
Episode #17
Givinostat ci ha portato in una nuova dimensione. Ora puntiamo a crescere nelle malattie rare - Di Marco (Italfarmaco)
Jun 8, 202612 minS1
La crescente attenzione verso le malattie rare è il risultato di due fattori convergenti: il progresso scientifico e la persistenza di bisogni clinici ancora insoddisfatti. Ne abbiamo parlato con Francesco di Marco Group CEO di Italfarmaco azienda italiana che opera in Italia e all’estero nel settore farmaceutico e chimico-farmaceutico. Ascolta ora l'episodio del podcast CSUITE - Riflessioni dei leader nel Life Science
Listen Show Notes
Episode #17
Rimettere la ricerca Biomedica al centro del sistema salute. L'intervista a Nicola Bencini (Incyte)
Nov 24, 202511 minS1
Nel comparto delle scienze della vita l’investimento medio in ricerca e sviluppo è pari al 15% dei ricavi, con punte fino all’80% nel biotech, contro circa il 5% dell’industria manifatturiera. Ne abbiamo parlato con Nicola Bencini Regional Vice President e General Manager di Incyte Italy, azienda biofarmaceutica specializzata nello sviluppo e la commercializzazione di terapie innovative, afferma come la ricerca deve tornare a essere una priorità strutturale del sistema salute. Ascolta ora l'episodio del podcast CSUITE - Riflessioni dei leader nel Life Science
Listen Show Notes
Episode #16
Rivoluzione genomica in oncologia, il ruolo centrale dell’NGS. L’intervista a Marco Cappelletti (Illumina)
Jul 2, 202518 minS1
Negli ultimi anni, il panorama della medicina oncologica è stato radicalmente trasformato grazie allo sviluppo delle tecnologie genomiche, in particolare del Next Generation Sequencing (NGS). Ne abbiamo parlato con Marco Cappelletti, Mediterranean Central Regional General Manager di Illumina, azienda leader nel settore delle analisi genomiche, che sottolinea come l’NGS sia oggi sempre più al centro della diagnostica clinica e della personalizzazione terapeutica. Ascolta ora l'episodio del podcast CSUITE - Riflessioni dei leader nel Life Science
Listen Show Notes

Advertisers on this show

Sponsor detection runs nightly. Check back soon.

Best industries to pitch C-Suite for

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

businessstrong

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.

Podcasts like C-Suite

All podcasts More business Top in US Top 100 by Booking Probability Booking Probability Index How scoring works How to get on podcasts

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.

FAQs

Every question we get asked before
someone starts their trial.

If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.

What is the difference between Founder Solo and Founder Pro?

Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.

How do agency tiers work?

Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.

What is a talent profile?

A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.

Can I switch plans later?

Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.

Do you offer a free trial?

Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.

What happens if I cancel?

You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.

Is the 20% annual discount automatic?

Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.

What if I have more than 50 profiles or 20 clients?

That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.

Every question we get asked before
someone starts their trial.

If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.

What is the difference between Founder Solo and Founder Pro?

How do agency tiers work?

What is a talent profile?

Can I switch plans later?

Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.

Do you offer a free trial?

Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.

What happens if I cancel?

You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.

Is the 20% annual discount automatic?

Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.

What if I have more than 50 profiles or 20 clients?

That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.

The platform

Free tools

By role

By need

Find shows

The data set

Live indexes

Browse by

Learn

Research & reads

C-Suite

About this Podcast:

Pitch Analysis

What is C-Suite?

About the host

Recent episodes

Farmaco vegetale, Linari (Bionorica): "Mercato strategico per lo sviluppo del settore".

Malattie rare, Di Marco (Italfarmaco): “Givinostat ci ha portato in una nuova dimensione"

Givinostat ci ha portato in una nuova dimensione. Ora puntiamo a crescere nelle malattie rare - Di Marco (Italfarmaco)

Rimettere la ricerca Biomedica al centro del sistema salute. L'intervista a Nicola Bencini (Incyte)

Rivoluzione genomica in oncologia, il ruolo centrale dell’NGS. L’intervista a Marco Cappelletti (Illumina)

Advertisers on this show

Best industries to pitch C-Suite for

Podcasts like C-Suite

Every question we get asked before
someone starts their trial.

C-Suite

About this Podcast:

Pitch Analysis

What is C-Suite?

About the host

Recent episodes

Farmaco vegetale, Linari (Bionorica): "Mercato strategico per lo sviluppo del settore".

Malattie rare, Di Marco (Italfarmaco): “Givinostat ci ha portato in una nuova dimensione"

Givinostat ci ha portato in una nuova dimensione. Ora puntiamo a crescere nelle malattie rare - Di Marco (Italfarmaco)

Rimettere la ricerca Biomedica al centro del sistema salute. L'intervista a Nicola Bencini (Incyte)

Rivoluzione genomica in oncologia, il ruolo centrale dell’NGS. L’intervista a Marco Cappelletti (Illumina)

Advertisers on this show

Best industries to pitch C-Suite for

Podcasts like C-Suite

Every question we get asked before
someone starts their trial.

C-Suite

About this Podcast:

Pitch Analysis

What is C-Suite?

About the host

Recent episodes

Farmaco vegetale, Linari (Bionorica): "Mercato strategico per lo sviluppo del settore".

Malattie rare, Di Marco (Italfarmaco): “Givinostat ci ha portato in una nuova dimensione"

Givinostat ci ha portato in una nuova dimensione. Ora puntiamo a crescere nelle malattie rare - Di Marco (Italfarmaco)

Rimettere la ricerca Biomedica al centro del sistema salute. L'intervista a Nicola Bencini (Incyte)

Rivoluzione genomica in oncologia, il ruolo centrale dell’NGS. L’intervista a Marco Cappelletti (Illumina)

Advertisers on this show

Best industries to pitch C-Suite for

Podcasts like C-Suite

Every question we get asked beforesomeone starts their trial.

C-Suite

About this Podcast:

Pitch Analysis

What is C-Suite?

About the host

Recent episodes

Farmaco vegetale, Linari (Bionorica): "Mercato strategico per lo sviluppo del settore".

Malattie rare, Di Marco (Italfarmaco): “Givinostat ci ha portato in una nuova dimensione"

Givinostat ci ha portato in una nuova dimensione. Ora puntiamo a crescere nelle malattie rare - Di Marco (Italfarmaco)

Rimettere la ricerca Biomedica al centro del sistema salute. L'intervista a Nicola Bencini (Incyte)

Rivoluzione genomica in oncologia, il ruolo centrale dell’NGS. L’intervista a Marco Cappelletti (Illumina)

Advertisers on this show

Best industries to pitch C-Suite for

Podcasts like C-Suite

Every question we get asked beforesomeone starts their trial.

Every question we get asked before
someone starts their trial.

Every question we get asked before
someone starts their trial.